#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune thrombocytopenia Infantile apnoea Plasma cell myeloma recurrent Phaeochromocytoma Kawasaki's disease Neuroendocrine cell hyperplasia of infancy Colitis ulcerative Hereditary angioedema with C1 esterase inhibitor deficiency Dedifferentiated liposarcoma Ovarian epithelial cancer Chorioretinitis Ehlers-Danlos syndrome Cutaneous T-cell lymphoma Infantile spasms Hairy cell leukaemia recurrent More trials…

    Learn about Rare Diseases

    Vascular malformation – Treatment Ewing’s sarcoma metastatic – Life with Disease Cystic fibrosis – Life with Disease Krabbe’s disease – Treatment Congenital hypotransferrinaemia – Treatment Hereditary neuropathic amyloidosis – Life with Disease Alexander disease Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Pleomorphic leiomyosarcoma – Basic Information Proteus syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-Glutamic Acid Chlorphenamine Maleate Melphalan Arginine Hydrochloride Cortisone Acetate Salmeterol Xinafoate Immunoglobulin M Nivolumab Isatuximab Lna043 Tigulixostat Naltrexone Hydrochloride SGT-003 Izaflortaucipir (18F) Fosfomycin IBUZATRELVIR Fezolinetant Darovasertib Difelikefalin Lasn01 More therapies…

    Learn about Your Condition

    Chronic fatigue syndrome Breast angiosarcoma Adenovirus infection Plasma cell myeloma recurrent Arthralgia Ocular melanoma Corneal dystrophy Chronic myeloid leukaemia Staphylococcal bacteraemia Diabetic foot infection Lumbosacral radiculopathy Allergic respiratory disease Acute promyelocytic leukaemia Erythema multiforme Thromboangiitis obliterans More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Glaucoma

  • Study on the Effectiveness of PRGF Eye Drops for Treating Dry Eye in Glaucoma Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glaucoma
    • Dry eye
    Investigated Drugs:
    • Platelet Concentrate
    Spain

  • Study on the Effects of Semaglutide for Patients with Glaucoma

    Recruiting

    3 1 1
    Investigated Diseases:
    • Glaucoma
    Investigated Drugs:
    • Semaglutide
    Denmark

  • Study Comparing Lidocaine Gel and Tetracaine/Oxybuprocaine Eye Drops for Glaucoma Patients Undergoing Outpatient Needling Procedures

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glaucoma
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Oxybuprocaine Hydrochloride
    • Tetracaine Hydrochloride
    Spain

  • Study on the Effects of Fibrin Matrix on Eye Health in Glaucoma Patients Using Long-Term Eye Pressure Medications

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Glaucoma
    Spain

  • Study Comparing Laser Treatment and Tafluprost Eye Drops for Patients with Exfoliation Glaucoma or Ocular Hypertension

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Glaucoma
    Investigated Drugs:
    • Tafluprost
    Finland

  • Study Comparing Lidocaine Gel and Tetracaine/Oxybuprocaine Eye Drops for Anesthesia in Glaucoma Patients Undergoing Needling Procedures

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Glaucoma
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Oxybuprocaine Hydrochloride
    • Tetracaine Hydrochloride
    Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!